According to Zacks, Zoetis Inc. (NYSE:ZTS) declared a quarterly dividend on December 8th. Stockholders who had records as of the company’s record date of Friday, January 20, will receive a dividend of 0.375 per share on March 1st. This has a yield of 0.98% and a $1.50 annual dividend value. The ex-dividend date for this dividend is January 19, a Thursday. This is an increase from Zoetis’ most recent quarterly dividend payment of $0.33.
For the past eight years, Zoetis has boosted its dividend payout each year, raising it by an average of 25.6% over the previous three years. The dividend of Zoetis is sufficiently covered by earnings, with a dividend payout ratio of 23.9%. Given that the company expects to earn $5.37 per share in the current year, Zoetis should be able to continue covering its $1.30 yearly dividend with a predicted future payment ratio of 24.2%.
The NYSE ZTS share price on Friday was $153.39 per share. The price of Zoetis has fluctuated between $124.15 and $249.27 over the past 52 weeks. The stock’s 200-day simple moving average is $160.48, and its 50-day simple moving average is $148.30. The debt-to-equity, quick, and current ratios for the corporation are each 1.12, 1.58, and 2.27, respectively. The business has a market cap of $71.49 billion, a P/E ratio of 35.02, a P/E/G ratio of 2.91, and a beta value of 0.72.
On November 3, Zoetis (NYSE:ZTS) announced its most recent earnings report. On November 3, the company reported quarterly earnings of $1.21 per share.The company’s quarterly earnings of $1.21 per share fell $0.05 short of the $1.24 average expectation. Zoetis had a return on equity of 48.41% and a net margin of 25.82%. The company’s revenue for the quarter was $2 billion, as opposed to the average estimate of $2.08 billion. During the same period last year, the company’s EPS was $1.25. The company’s sales for the quarter climbed by 6.4% when compared to the same period last year. Research experts forecast that Zoetis will generate $4.87 in earnings per share for the current fiscal year.
Recently, shares of ZTS were bought and sold by hedge funds. Worth Asset Management LLC put about $26,000 into a new Zoetis position during the first quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC increased its ownership of Zoetis by 430.8% in the first quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 138 shares of the company’s stock, valued at $26,000, after acquiring an additional 112 shares over the last three months. Fairfield Bush & Co. acquired a new interest in Zoetis during the first quarter, totaling around $134,000. Covestor Ltd. increased its ownership of Zoetis by 102.8% during the first quarter. Covestor Ltd. increased its share count by 367 shares, or 724 shares, totaling $137,000 more than it did at the beginning of the quarter. Not to mention that during the first quarter, Bridgefront Capital LLC increased its holding in Zoetis by nearly $220,000. Institutions own 91.05% of the company’s shares.
Several analysts have recently published reports on ZTS shares. The Goldman Sachs Group downgraded its price target for Zoetis from $207.00 to $180.00 and rated the stock as a “buy” in a research note released on Friday, November 4th. JPMorgan Chase & Co. lowered their price target for Zoetis from $250 to $225 in a research report released on Monday, October 17th, while maintaining an “overweight” rating on the stock. In a research note released on Tuesday, November 15, Morgan Stanley lowered its “overweight” rating on Zoetis and its price objective for the firm from $264.00 to $248.00. A research report on Zoetis was published on October 12 by StockNews.com. They gave the business a “buy” grade. Finally, William Blair reiterated an “outperform” recommendation for Zoetis shares in a research note that was released on Thursday, November 3. One research analyst has recommended buying the stock, while seven other analysts have given the company a buy rating. According to Bloomberg.com, the business now has a consensus “Moderate Buy” rating and a consensus price target of $215.17.
The company Zoetis, Inc. conducts research, develops, manufactures, and promotes products for animal health on both local and international markets. It primarily commercializes goods from a number of species, including livestock like cattle, swine, poultry, fish, and sheep, as well as companion animals like dogs, cats, and horses.
Discussion about this post